表观遗传学
生物
全基因组关联研究
单核苷酸多态性
染色质
表观遗传学
遗传学
表型
疾病
计算生物学
基因
神经科学
基因表达
医学
基因型
病理
DNA甲基化
作者
M. Ryan Corces,Anna Shcherbina,Soumya Kundu,Michael J. Gloudemans,Laure Frésard,Jeffrey M. Granja,Bryan H. Louie,Shadi Shams,S. Tansu Bagdatli,Maxwell R. Mumbach,Bosh Liu,Kathleen S. Montine,William J. Greenleaf,Anshul Kundaje,Stephen B. Montgomery,Howard Y. Chang,Thomas J. Montine
标识
DOI:10.1101/2020.01.06.896159
摘要
ABSTRACT Genome-wide association studies (GWAS) have identified thousands of variants associated with disease phenotypes. However, the majority of these variants do not alter coding sequences, making it difficult to assign their function. To this end, we present a multi-omic epigenetic atlas of the adult human brain through profiling of the chromatin accessibility landscapes and three-dimensional chromatin interactions of seven brain regions across a cohort of 39 cognitively healthy individuals. Single-cell chromatin accessibility profiling of 70,631 cells from six of these brain regions identifies 24 distinct cell clusters and 359,022 cell type-specific regulatory elements, capturing the regulatory diversity of the adult brain. We develop a machine learning classifier to integrate this multi-omic framework and predict dozens of functional single nucleotide polymorphisms (SNPs), nominating gene and cellular targets for previously orphaned GWAS loci. These predictions both inform well-studied disease-relevant genes, such as BIN1 in microglia for Alzheimer’s disease (AD) and reveal novel gene-disease associations, such as STAB1 in microglia and MAL in oligodendrocytes for Parkinson’s disease (PD). Moreover, we dissect the complex inverted haplotype of the MAPT (encoding tau) PD risk locus, identifying ectopic enhancer-gene contacts in neurons that increase MAPT expression and may mediate this disease association. This work greatly expands our understanding of inherited variation in AD and PD and provides a roadmap for the epigenomic dissection of noncoding regulatory variation in disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI